C-kit gene mutations in adenoid cystic carcinoma are rare.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed.

1. Investigational multitargeted kinase inhibitors in development for head and neck neoplasms.Expert opinion on investigational drugs · 2019
   Review
2. Adenoid cystic carcinoma of the breast: Experience at a tertiary care centre of Northern India.International journal of surgery case reports · 2018
   Article
3. Applications of molecular testing in surgical pathology of the head and neck.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2017
   Review
4. c-Kit Expression is Rate-Limiting for Stem Cell Factor-Mediated Disease Progression in Adenoid Cystic Carcinoma of the Salivary Glands.Translational oncology · 2014
   Article
5. Adenoid cystic carcinoma: clinical and molecular features.Head and neck pathology · 2013
   Review
6. Molecular biology of adenoid cystic carcinoma.Head & neck · 2012
   Review

Corrections and comments

• Comment on
  Identification of c-kit gene mutations in primary adenoid cystic carcinoma of the salivary gland.2009

Authors and funding

4 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as